The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126162411 12616241 1 I 20160721 20160802 20160802 EXP NL-TEVA-681525ISR TEVA BOOT E, BUTCHER NJ, VAN AMELSVOORT TAMJ, LANG AE, MARRAS C, PONDAL M ET AL. MOVEMENT DISORDERS AND OTHER MOTOR ABNORMALITIES IN ADULTS WITH 22Q11.2 DELETION SYNDROME.AMERICAN JOURNAL OF MEDICAL GENETICS, PART A. 2015; 167(3):639-645 37.00 YR M Y 0.00000 20160802 MD NL NL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126162411 12616241 1 PS QUETIAPINE. QUETIAPINE 1 U 77745 700 MG

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
126162411 12616241 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126162411 12616241 Oculogyric crisis
126162411 12616241 Seizure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found